Despite all the developments made in reproductive science since the first “test tube” baby was born in 1978, there was still no test available to gauge the quality of a human egg. So Future Fertility, led by Diana Olusanmi, set out to change that. Her company offers AI-driven software that can calculate the health and reproductive likelihood of a human egg based on a 2D image. “There is a strong demand for greater transparency,” says Olusanmi. Since launching its first product this September, Future Fertility has heard from fertility clinics from all over the EU, Brazil, Malaysia and Japan.
What’s next: Future Fertility’s top priority for 2021 is to further refine the product and increase accuracy, which is currently 20 percent better than embryologists at predicting the likelihood of an egg becoming an embryo. The company is planning to close a Series A funding round in the first quarter of next year.
